Patient Safety Indicator Example
Case Study: Emergency Department (ED) Delayed Testing Results Due to Specimen Rejection
Background/Facility Information
– 150-bed rural hospital
– ED utilizes contracted physicians for coverage
– ED Blood Specimen Collection: performed by ED staff (patient care techs and nurses)
– Laboratory Department: performs high complexity testing with an extensive test menu; 24/7 coverage
Performance Problem Identification
Suspected Problem Reported and Source:
– Laboratory received formal complaint from one of the newer contracted physicians
– Complaint: unacceptable laboratory testing turnaround time is causing delayed diagnosis, delayed treatment, and is negatively impacting the flow of patient admissions
– Two specific patients’ names were documented
Actions Taken in Response to Complaint:
– Immediate review of the documented patients’ records was completed
– Delayed testing results were confirmed; records documented that both patients had rejected specimens that required specimens to be redrawn
– A brief review of all patients seen in the ED in the last 10 days was completed to determine if the two patients were isolated cases. Review results:
- 100 patients received ED services that required laboratory testing
- 15 of the 100 patients had documented rejected specimens (15% of the patients were impacted)
- 400 total specimens were received from the 100 patients; 45 specimens of the 400 were documented as specimen rejected and required redraws (11.3% rejection rate)
- Reasons for rejection included: specimen integrity (hemolysis) (35), specimen labeling error (7), specimen not received (3)
- Laboratory leaders met with ED physicians and nursing staff.
- It was determined that an 11.3% rejection rate was negatively impacting patient outcomes
- It was decided to implement a Patient Safety initiative to “decrease the ED specimen rejection rate to <2%”
- Laboratory designated as the lead department for the initiative and would include appropriate representation of ED physicians, nurses, and patient care techs
- Laboratory proceeded to develop the “Patient Safety Indicator” to be used in the initiative
Patient Safety Indicator – Title & Form
Delayed Test Results Due to Specimen Rejection:
– Refer to “Patient Safety Indicator example form”
Indicator Metrics & Generalized Plan/Do/Study/ Act (PDSA) Information
– 10-Day Snapshot Rejection Rate: 11.3%
– 2-Month Baseline Assessment:
- November 2020 Rejection Rate: 10.5%
- December 2020 Rejection Rate: 10.9%
- Improvement Actions: No change actions were implemented during baseline assessment
- Processes were evaluated (specimen collection and transport)
- Areas for improvement were identified (e.g., education on specimen collection, handling, transportation would be completed for four new employees, education would be provided for all staff to decrease the # of line draws that were being performed
– January 2021 Rejection Rate: 7.0%
- Specimen rejection occurrences were reviewed, and improvement actions identified and implemented
- Two new ED staff members since December 2020; specimen collection and handling errors again noted
- It was noted that non-laboratory staff was responsible for new ED staff orientation and training
- Specimen collection and handling training and competency process reviewed and updated
- It was decided that laboratory staff would begin performing new ED staff specimen collection, handling, and transport orientation and training beginning February 2021
- Monthly competency assessments by observation were implemented
Indicator Metrics & Generalized Plan/Do/Study/ Act (PDSA) Information
– February 2021 Rejection Rate: 6.5%
- Specimen rejection occurrences and competency assessment outcomes were reviewed, and improvement actions identified and implemented
- Specimen handling and transport errors by multiple staff noted
- Education on specimen handling and transport was provided for all specimen collection staff
– March 2021 Rejection Rate: 4.0%
– Refer to “Patient Safety Indicator Tracking & Graph Example”
(Note: Process, staff performance and specimen rejection reviews continue, improvement actions are implemented, and the indicator requirements continue until target is reached and maintained)